Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study
Open Access
Abstract
The present study aimed to assess antibody seropositivity prevalence among symptomatic individuals and individuals with a high risk of occupational exposure to SARS-CoV-2. Participants from Chelyabinsk (Russian Federation) who were at an increased risk of exposure to SARS-CoV-2 (high-risk group, n = 1091) and participants who either had symptoms consistent with COVID-19 or were suspected to have experienced COVID-19 in the past (symptomatic group, n = 692) were enrolled between 28 September and 30 December 2020. Blood samples were tested by enzyme-linked immunosorbent assay D-5501 SARS-Cov-2-IgG-EIA-BEST and D-5502 SARS-Cov-2-IgM-EIA-BEST (AO Vector-Best, Novosibirsk, Russia). The overall seropositivity rate was 28.33–28.53%. SARS-CoV-2 antibodies were detected in 17.23% (adjusted prevalence of 17.17–17.29%) of participants in the high-risk and 45.95% (adjusted prevalence of 45.91–46.24%) in the symptomatic group. Higher IgG and IgM titers were observed in women compared to men, as well as in participants in the symptomatic group compared to those in the high-risk group. The results indicate that the seroprevalence among residents in several Russian regions is low (28.38%) and inadequate to provide herd immunity. The lower seroprevalence among participants in the high-risk group may be attributed to the enforcement of healthcare protocols and the use of adequate personal protective equipment.Keywords
Funding Information
- Russian Foundation for Basic Research (20-515-55003)
- National Natural Science Foundation of China (project No. 82161138003)
- Government contract of the Institute of Immunology and Physiology (АААА-А21-121012090090-9)
This publication has 53 references indexed in Scilit:
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic periodScience, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- [Investigation on a cluster epidemic of COVID-19 in a supermarket in Liaocheng, Shandong province].2020
- Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family clusterEmerging Microbes & Infections, 2020
- Biological sex affects vaccine efficacy and protection against influenza in miceProceedings of the National Academy of Sciences, 2018
- Sex Hormones Regulate Innate Immune Cells and Promote Sex Differences in Respiratory Virus InfectionFrontiers in Immunology, 2018
- Sex-based differences in immune function and responses to vaccinationTransactions of the Royal Society of Tropical Medicine and Hygiene, 2015
- Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccinationProceedings of the National Academy of Sciences, 2013
- Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalitiesClinical and Experimental Immunology, 2007
- Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirusClinical Microbiology and Infection, 2004